Full-Time
Quality Control Analyst
Posted on 9/19/2024
Synthego
201-500 employees
Provides synthetic RNA and gene editing tools
Compensation Overview
$30 - $34Hourly
Entry, Junior
San Carlos, CA, USA
Position requires onsite presence in Redwood City, CA.
- Bachelor’s degree in Biology, Chemistry, Molecular Biology, or equivalent technical field.
- 1+ years in a regulated Quality Control or similar role with working knowledge of cGMP.
- Be able to analyze, understand and effectively communicate technical material.
- Be able to organize and prioritize tasks in a dynamic work environment.
- Perform automated and manual assays as detailed in established SOPs and QC test method procedures, including raw material, in-process and finished product.
- Conduct QC testing with a variety of analytical techniques such as LC/MS, HPLC, GC, UV/Vis, Endotoxin, Raman spectroscopy, PCR, and NGS.
- Interpret test results against specifications to support material dispositioning.
- Perform testing for product stability, environmental monitoring, endotoxins, and bioburden as required.
- Maintain complete and accurate production records in conformance with GMP and FDA requirements.
- Support routine preventive maintenance, general troubleshooting, general cleanliness and calibration of laboratory equipment.
- Support internal and external customer inquiries and requests as relevant to product quality and integrity.
- Trend EM and QC data results.
- Update departmental SOPs and QC test procedures.
- Order required laboratory supplies, reagents and other consumables.
- Monitor proper storage conditions and expiration dates.
- Dispose of hazardous and biohazardous materials.
- Maintain samples in accordance with established procedures.
- Prepare QC test samples required for QC functional testing.
- Perform other duties as assigned.
Synthego specializes in biotechnology, focusing on genetic engineering by providing synthetic RNA and gene editing tools. Their products enable scientists to modify genes, which can lead to advancements in disease treatment and agricultural improvements. Synthego serves a variety of clients, including research institutions, pharmaceutical companies, and biotech startups, who utilize their products for drug discovery, disease modeling, and genetic research. The company stands out in the growing genetic engineering market by offering a platform that grants users access to advanced gene editing capabilities, alongside their synthetic RNA products. Synthego's goal is to support and enhance genetic research and applications through their tools and services.
Company Stage
Series E
Total Funding
$459.7M
Headquarters
Menlo Park, California
Founded
2012
6 month growth
↓ -10%1 year growth
↓ -37%2 year growth
↓ -56%
Simplify's Take
What believers are saying
- Synthego's licensing agreement with HuidaGene for the hfCas12Max nuclease positions it at the forefront of CRISPR-based therapeutic applications.
- The addition of Dr. Bill Skarnes to the advisory board and the launch of high-throughput induced pluripotent stem cell genome engineering highlight Synthego's commitment to innovation and expertise.
- The opening of a new GMP synthesis facility and the launch of IND-enabling gRNAs bolster Synthego's support for the entire discovery-to-clinic continuum, enhancing its market position.
What critics are saying
- The rapid pace of innovation in the genetic engineering field requires Synthego to continuously advance its technologies to stay competitive.
- Leadership changes, such as the recent CEO transition, could lead to strategic shifts and potential instability within the company.
What makes Synthego unique
- Synthego's focus on synthetic RNA and advanced gene editing tools, such as the high-fidelity Cas12 CRISPR nuclease, sets it apart from competitors who may not offer such specialized products.
- The company's strategic partnerships, like those with HuidaGene and bit.bio, enhance its capabilities in developing next-generation CRISPR-based therapies and synthetic circuitry in cells.
- Synthego's state-of-the-art GMP manufacturing facility ensures high-quality production of CRISPR components, providing a competitive edge in the clinical development of gene editing therapies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Generous Equity Package
Medical, Dental & Vision
401(k) Plan
Catered to You
Fully Stocked
Transportation
Green Environment
Stay Fit
Legal Ease